title: Pharmacological modulation of peritoneal injury induced by dialysis fluids: is it an option?
authors.forename: Guadalupe Tirma
authors.initials: GT
authors.lastname: González-Mateo
authors.forename: Luiz Stark
authors.initials: LS
authors.lastname: Aroeira
authors.forename: Manuel
authors.initials: M
authors.lastname: López-Cabrera
authors.forename: Marta
authors.initials: M
authors.lastname: Ruiz-Ortega
authors.forename: Alberto
authors.initials: A
authors.lastname: Ortiz
authors.forename: Rafael
authors.initials: R
authors.lastname: Selgas
mesh_terms: D000818:Animals; D000068579:Celecoxib; D015314:Dialysis Solutions / Q000009:adverse effects* / Q000494:pharmacology; D004195:Disease Models, Animal; D004656:Enalapril / Q000494:pharmacology; D005260:Female; D006801:Humans; D008297:Male; D051379:Mice; D010530:Peritoneal Dialysis / Q000009:adverse effects* / Q000379:methods; D010532:Peritoneal Diseases / Q000139:chemically induced* / Q000188:drug therapy*; D010537:Peritoneum / Q000187:drug effects; D004364:Pharmaceutical Preparations / Q000008:administration & dosage*; D011446:Prospective Studies; D011720:Pyrazoles / Q000494:pharmacology; D051381:Rats; D000077154:Rosiglitazone; D012680:Sensitivity and Specificity; D013449:Sulfonamides / Q000494:pharmacology; D045162:Thiazolidinediones / Q000494:pharmacology
chemical_list: D015314:Dialysis Solutions; D004364:Pharmaceutical Preparations; D011720:Pyrazoles; D013449:Sulfonamides; D045162:Thiazolidinediones; D000077154:Rosiglitazone; D004656:Enalapril; D000068579:Celecoxib